Tobishi Pharmaceutical Co., Ltd.

Hirobumi Senga

Yongling Wan

Lishui Chang

Masato Honma

Caixia Li

Li Li

Dingfang Cai

Zhongchao Han

The present invention provides an agent for reducing a side effect of an anticancer drug, which comprises a thrombin-like enzyme.

Thrombin-like enzyme for reducing a side effect of an anticancer drug

The present invention provides a therapeutic agent for a lower urinary tract disease such as cystitis, interstitial cystitis, prostatitis, benign prostatic hyperplasia etc., which are considered as refractory disease, and an agent for improving a lower urinary tract symptom associated with the lower urinary tract disease.

Therapeutic agent for a lower urinary tract disease and an agent for improving a lower urinary tract symptom

A malignant tumor-inhibiting preparation is provided which comprises Des A fibrin and therefore can inhibit the spreading and migration of malignant tumor cells and thereby can inhibit the malignant tumors.

Malignant tumor-inhibiting preparation comprising Des A fibrin

A preparation for inhibiting local invasion of malignant tumors is provided which comprises batroxobin and therefore can inhibit local invasion of malignant tumors. A preparation for encapsulating malignant tumor tissues is also provided which comprises batroxobin and therefore can cause or promote formation of capsule-like tissue around malignant tumor tissues.

Growing community of inventors

Tokyo, Japan

Hirobumi Senga